Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The overall objective of this application is to therapeutically target the dysfunctional premotor-motor interaction in dystonia-and to provide a focused treatment of specific anatomical networks in order to reduce side effects and to improve symptom control over conventional therapies.
Full description
We propose using repetitive transcranial magnetic stimulation (rTMS) over distinct premotor areas in patients with cervical dystonia (CD) with the goal of improving symptoms and reducing unwanted side effects. The knowledge gained in this proposed research will identify a specific premotor area to be targeted with rTMS that is expected to result in a novel intervention that could enhance or replace current treatments for CD. rTMS could be included as an adjunct treatment to botulinum toxin that could sustain treatment effect and decrease the frequency of re-injection, potentially resulting in cost savings without a decrease in symptom control. In addition to medical cost reduction, improved quality of life could be expected with the successful development of therapies that extend dystonia symptom control. rTMs has been FDA-approved for the treatment of depression and our proposal uses an even lower stimulation rate, suggesting continued use within clearly safe parameters. Successful completion of this research could lead to rapid adoption of this therapeutic modality.
We will test the hypothesis that rTMS of a distinct premotor site will provide more effective treatment of CD than non-specific activation of the entire premotor region. This will be done by performing a randomized, observer-blinded exploratory pilot study to determine the optimal site of rTMS over various sites of the premotor and motor cortex to improve the symptoms of cervical dystonia. Completion of this aim should lead to development of targeted TMS therapy for CD.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Clinical diagnosis of idiopathic cervical dystonia
- Age 18 years or older
- Normal findings in the medical history, physical and neurological examination, except for dystonia
- Last treatment with botulinum toxin more than two months ago
Exclusion criteria
- History of seizure disorder
- Pregnancy- a pregnancy test will be performed for women of childbearing potential
- History of any other neurological disorders or conditions requiring the use of anti-depressants that are known to increase seizure threshold, neuroleptic medication, anticholinergic drugs and muscle relaxants
- History of neuroleptic medications/ prior use of neuroleptics
Trial design
Primary purpose
Allocation
Interventional model
Masking
8 participants in 5 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal